A detailed history of Huntington National Bank transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Huntington National Bank holds 201 shares of TMDX stock, worth $14,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
201
Previous 110 82.73%
Holding current value
$14,508
Previous $17,000 29.41%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$59.28 - $144.9 $5,394 - $13,185
91 Added 82.73%
201 $12,000
Q3 2024

Nov 06, 2024

BUY
$135.68 - $176.11 $1,356 - $1,761
10 Added 10.0%
110 $17,000
Q2 2024

Aug 08, 2024

SELL
$72.62 - $150.62 $19,897 - $41,269
-274 Reduced 73.26%
100 $15,000
Q1 2024

May 03, 2024

BUY
$70.86 - $89.93 $5,456 - $6,924
77 Added 25.93%
374 $27,000
Q3 2023

Nov 08, 2023

SELL
$53.47 - $96.07 $3,101 - $5,572
-58 Reduced 16.34%
297 $16,000
Q2 2023

Aug 11, 2023

BUY
$66.23 - $88.73 $23,511 - $31,499
355 New
355 $29,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.3B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.